Lymphoscintigraphic localization of sentinel node in early colorectal cancer: Results of a monocentric study

Journal of Surgical Oncology

Volumn 96, Issue 6, 2007, Pages 464-469

  Sandrucci, Sergio ^a,b   Mussa, Baudolino ^a   Goss, Matteo ^a   Mistrangelo, Massimiliano ^a   Satolli, Maria Antonietta ^a   Sapino, Anna ^a   Bellò, Marilena ^a   Bisi, Gianni ^a   Mussa, Antonio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Blue dye; Early colorectal cancer; Labeled albumin colloids; Sentinel node

Indexed keywords

ALBUMIN TC 99M;

ADULT; AGED; ARTICLE; CANCER SCINTISCANNING; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL TRIAL; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MALE; PRIORITY JOURNAL; RELIABILITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

COLORECTAL NEOPLASMS; FEASIBILITY STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; ROSANILINE DYES; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 35748961123     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20848     Document Type: Article

References (48)

1. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
2. Morton DL, Hoon DS, Cochran AJ, et al.: Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003;238:538-549.
3. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
4. Rodier JF, Routiot T, Mignotte H, et al.: Lymphatic mapping and sentinel node biopsy of operable breast cancer. World J Surg 2000;24:1220-1226.
5. Veronesi U, Paganelli G, Galimberti V, et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-1867.
6. Yao KA, Hsueh EC, Essner R, et al.: Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma? Ann Surg 2003;238:743-747.
7. Cawthorn SJ, Gibbs NM, Marks CG: Clearance technique for the detection of lymph nodes in colorectal cancer. Br J Surg 1986; 73:58-60.
8. Cserni G, Vajda K, Tarjan M, et al.: Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 1999;5: 291-296.
9. Wiese DA, Saha S, Badin J, et al.: Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma. Arch Pathol Lab Med 2000;124:1759-1763.
10. Broderick-Villa G, Ko A, O'Connell TX, et al.: Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer? Cancer J 2002;8:445-450.
11. Feig BW, Curley S, Lucci A, et al.: A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 2001;182:707-712.
12. Paramo JC, Summerall J, Poppiti R, et al.: Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 2002;9:550-554.
13. Saha S, Wiese D, Badin J, et al.: Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000;7:120-124.
14. Wood TF, Nora DT, Morton DL, et al.: One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: Detection of missed micrometastases. J Gastrointest Surg 2002;6:322-329.
15. Bilchik AJ, Nora D, Tollenaar RA, et al.: Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer 2002;38:977-985.
16. Bendavid Y, Latulippe JF, Younan RJ, et al.: Phase I study on sentinel lymph node mapping in colon cancer: A preliminary report. J Surg Oncol 2002;79:81-84.
17. Nastro P, Sodo M, Dodaro CA, et al.: Intraoperative radio-chromoguided mapping of sentinel lymph node in colon cancer. Tumori 2002;88:352-353.
18. Kitagawa Y, Watanabe M, Hasegawa H, et al.: Sentinel node mapping for colorectal cancer with radioactive tracer. Dis Colon Rectum 2002;45:1476-1480.
19. Wong JH, Steineman S, Calderia C, et al.: Ex vivo sentinel node mapping in carcinoma or the colon and rectum. Ann Surg 2001; 233:515-521.
20. Fitzgerald TL, Khalifa MA, Al Zahrani M, et al.: Ex vivo sentinel lymph node biopsy in colorectal cancer: A feasibility study. J Surg Oncol 2002;80:27-32.
21. Saha S, Bilchik A, Wiese D, et al.: Ultrastaging of colorectal cancer by sentinel node mapping - A multi-center trial. Ann Surg Oncol 2001;8:94S-98S.
22. Pozza E, Ascanelli S, Turini A, et al.: Impact of the sentinel lymph node in the staging of colorectal carcinoma. Chir Ital 2002;54: 659-665.
23. Merrie AE, van Rij AM, Phillips LV, et al.: Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 2001;44:410-417.
24. Joosten JJ, Strobbe LJ, Wauters CA, et al.: Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482-486.
25. Borgstein PJ, Pijpers R, Comans EF, et al.: Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186: 275-283.
26. Saha S, Dan AG, Berman B, et al.: Lymphazurin 1% versus (99m)tc sulfur colloid for lymphatic mapping in colorectal tumors: A comparative analysis. Ann Surg Oncol 2004;11:21-26.
27. Nastro P, Sodo M, Dodaro CA, et al.: Intraoperative radio-chromoguided mapping of sentinel lymph node in colon cancer. Tumori 2002;88:352-353.
28. Patten LC, Berger DH, Rodriguez-Bigas M, et al.: A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer 2004;100:2104-2109.
29. Bembenek A, Rau B, Moesta T, et al.: Sentinel lymph node biopsy in rectal cancer - Not yet ready for routine clinical use. Surgery 2004;135:498-505.
30. Gandy CP, Biddlestone LR, Roe AM, et al.: Intraoperative injection of Patent Blue V dye to facilitate nodal staging in colorectal cancer. Colorectal Dis 2002;4:447-449.
31. Kitagawa Y, Fujii H, Mukai M, et al.: The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000;80:1799-1809.
32. Wood TF, Spirt M, Rangel D, et al.: Lymphatic mapping improves staging during laparoscopic colectomy for cancer. Surg Endosc 2001;15:715-719.
33. Wood TF, Tsioulias GJ, Morton DL, et al.: Focused examination of sentinel lymph nodes upstages early colorectal carcinoma. Am Surg 2000;66:998-1003.
34. Tsioulias GJ, Wood TF, Spirt M, et al.: A novel lymphatic mapping technique to improve localization and staging of early colon cancer during laparoscopic colectomy. Am Surg 2002;68: 561-565.
35. Merrie AE, Phillips LV, Yun K, et al.: Skip metastases in colon cancer: Assessment by lymph node mapping using molecular detection. Surgery 2001;129:684-691.
36. Dahl K, Westlin J, Kraaz W, et al.: Identification of sentinel nodes in patients with colon cancer. Eur J Surg Oncol 2005;31: 381-385.
37. Saha S, Bilchik A, Wiese D, et al.: Ultrastaging of colorectal cancer by sentinel lymph node mapping technique: A multicenter trial. Ann Surg Oncol 2001;89:94S-98S.
38. Grinnell RS: Lymphatic block with atypical and retrograde lymphatic metastasis and spread in carcinoma of the colon and rectum. Ann Surg 1966;163:272-280.
39. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al: Micro-metastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-228.
40. Mori M, Mimori K, Ueo H, et al.: Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998;16:128-132.
41. Rosenberg R, Hoos A, Mueller J, et al.: Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 2002;20:1049-1055.
42. Noura S, Yamamoto H, Ohnishi T, et al.: Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 2002;20:4232-4241.
43. Doekhie FS, Peeters KCMJ, Kuppen PJK, et al.: The feasibility and reliability of sentinel node mapping in colorectal cancer. Eur J Surg Oncol 2005;31:854-862.
44. Tsavellas G, Patel H, Allen-Mersh TG: Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Surg 2001;88:1307-1320.
45. Sasaki M, Watanabe H, Jass JR, et al.: Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer. J Gastroenterol 1997;32:758-764.
46. Oberg A, Stenling R, Tavelin B, et al.: Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244-1249.
47. Yasuda K, Adachi Y, Shiraishi N, et al.: Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001;8:300-304.
48. Choi HJ, Choi YY, Hong SH: Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum 2002; 45:750-755.